series-c-plus
Stage
1
Investors
About
Naurex is a biotechnology company developing novel treatments for neurological and psychiatric disorders by focusing on mechanisms underlying neuroplasticity and central nervous system function.
Explore Naurex's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.